A possible etiology of contractility impairment of vascular smooth muscle from spontaneously hypertensive rats.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000473:pathology; D001464:Barium / Q000494:pharmacology; D001794:Blood Pressure; D002118:Calcium / Q000494:pharmacology; D003035:Cobalt / Q000494:pharmacology; D006973:Hypertension / Q000235:genetics / Q000503:physiopathology*; D066298:In Vitro Techniques; D007811:Lanthanum / Q000494:pharmacology; D008345:Manganese / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects*; D005996:Nitroglycerin / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D009929:Organ Size; D010042:Ouabain / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D013324:Strontium / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D001464:Barium; D003035:Cobalt; D008345:Manganese; D010042:Ouabain; D007811:Lanthanum; D010208:Papaverine; D005996:Nitroglycerin; D011188:Potassium; D002118:Calcium; D009638:Norepinephrine; D013324:Strontium